Cargando…
ONECUT2 as a new therapeutic target in androgen receptor-indifferent prostate cancer
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798022/ https://www.ncbi.nlm.nih.gov/pubmed/35117025 http://dx.doi.org/10.21037/tcr.2019.10.15 |
| _version_ | 1784641695018647552 |
|---|---|
| author | Freeman, Michael R. Rotinen, Mirja You, Sungyong |
| author_facet | Freeman, Michael R. Rotinen, Mirja You, Sungyong |
| author_sort | Freeman, Michael R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8798022 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87980222022-02-02 ONECUT2 as a new therapeutic target in androgen receptor-indifferent prostate cancer Freeman, Michael R. Rotinen, Mirja You, Sungyong Transl Cancer Res Letter to the Editor AME Publishing Company 2019-11 /pmc/articles/PMC8798022/ /pubmed/35117025 http://dx.doi.org/10.21037/tcr.2019.10.15 Text en 2019 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
| spellingShingle | Letter to the Editor Freeman, Michael R. Rotinen, Mirja You, Sungyong ONECUT2 as a new therapeutic target in androgen receptor-indifferent prostate cancer |
| title | ONECUT2 as a new therapeutic target in androgen receptor-indifferent prostate cancer |
| title_full | ONECUT2 as a new therapeutic target in androgen receptor-indifferent prostate cancer |
| title_fullStr | ONECUT2 as a new therapeutic target in androgen receptor-indifferent prostate cancer |
| title_full_unstemmed | ONECUT2 as a new therapeutic target in androgen receptor-indifferent prostate cancer |
| title_short | ONECUT2 as a new therapeutic target in androgen receptor-indifferent prostate cancer |
| title_sort | onecut2 as a new therapeutic target in androgen receptor-indifferent prostate cancer |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798022/ https://www.ncbi.nlm.nih.gov/pubmed/35117025 http://dx.doi.org/10.21037/tcr.2019.10.15 |
| work_keys_str_mv | AT freemanmichaelr onecut2asanewtherapeutictargetinandrogenreceptorindifferentprostatecancer AT rotinenmirja onecut2asanewtherapeutictargetinandrogenreceptorindifferentprostatecancer AT yousungyong onecut2asanewtherapeutictargetinandrogenreceptorindifferentprostatecancer |